A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
Clinical trial NCT00960063 · TERMINATED
Trial details
- NCT number
- NCT00960063
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-11
- Primary completion
- 2010-12-22
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.